Epigenetic study provides new approaches to combination therapies for aggressive cancers - Science Daily

Epigenetic study provides new approaches to combination therapies for aggressive cancers  Science Daily

A recent study reveals how the interaction of the epigenetic protein BRD4 with the metabolic enzyme MTHFD1 controls gene expression and cell proliferation.